marine link image
Register now for the Port of the Future Conference • 2 Days, 50 Ports • Houston/Galveston area, TX • April 12–14, 2027

URS Appoints Engle National Director

November 14, 2013

Gary Engle
Gary Engle

URS Corporation has named Gary Engle its National Director of the Federal Business Line for Infrastructure &Environment. A URS Senior Vice President, Mr. Engle joined the company in January 2007 following a 28-year military career.

A Rear Admiral, Civil Engineer Corps, U.S. Navy (Retired), Mr. Engle previously served as a Vice President for the Federal Business Line, focusing on its Department of Defense (DoD) program and leading Navy and Marine Corps work globally for projects involving the full range of facility and infrastructure services, including design-build, design, construction, environmental, contingencies, and planning.

Mr. Engle currently serves as National President of the Society of American Military Engineers (SAME). He is a Registered Professional Engineer and a member of the Design-Build Institute of America (DBIA). He holds a master’s degree in civil engineering from the University of Michigan and is a graduate of Carnegie Mellon’s Advanced Management Program.

urs.com
 

Logistics News

A Ceasefire Would Allow Russia to Restart 80% of Black Sea Grain Export Terminals

A Ceasefire Would Allow Russia to Restart 80% of Black Sea Grain Export Terminals

Aderco's 2055G+: Emissions Performance with Shared, Verifiable Data

Aderco's 2055G+: Emissions Performance with Shared, Verifiable Data

ARC Freedom Enters ARC's U.S.-Flagged Fleet

ARC Freedom Enters ARC's U.S.-Flagged Fleet

NYK Contributes to Industry Insight on Ammonia-Fueled Vessels at IMO

NYK Contributes to Industry Insight on Ammonia-Fueled Vessels at IMO

Subscribe for Maritime Logistics Professional E‑News

Maguire: Rapid EV adoption in the US fuel market has caused a split.
Sources say that traders are pushing for lower prices for Venezuelan crude oil, as shipping costs have risen.
Denmark's central banks expects a 4% growth in GDP by 2026, driven by the pharmaceutical industry